Mostrar el registro sencillo del ítem
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
dc.contributor.author | Rodríguez Carrio, Javier | |
dc.contributor.author | Burska, A. | |
dc.contributor.author | Conaghan, P. G. | |
dc.date.accessioned | 2023-06-26T09:03:33Z | |
dc.date.available | 2023-06-26T09:03:33Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | RMD Open, 9(1) (2023); doi:10.1136/rmdopen-2022-002864 | |
dc.identifier.issn | 2056-5933 | |
dc.identifier.uri | http://hdl.handle.net/10651/68620 | |
dc.description.sponsorship | EULAR [SCI019]; UK National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre | |
dc.description.statementofresponsibility | Rodríguez-Carrio J, Burska A, Conaghan PG, Dik WA, Biesen R, Eloranta ML, Cavalli G, Visser M, Boumpas DT, Bertsias G, Wahren-Herlenius M, Rehwinkel J, Frémond ML, Crow MK, Ronnblom L, Vital E, Versnel M | |
dc.language.iso | eng | |
dc.relation.ispartof | RMD Open | |
dc.rights | © Author(s) (or their employer(s)) 2023 | |
dc.rights | CC Reconocimiento 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85149596915&doi=10.1136%2frmdopen-2022-002864&partnerID=40&md5=ef2362b5cfc6f97372d57901ff25f67f | |
dc.title | Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider | |
dc.type | journal article | |
dc.identifier.doi | 10.1136/rmdopen-2022-002864 | |
dc.relation.publisherversion | http://dx.doi.org/10.1136/rmdopen-2022-002864 | |
dc.rights.accessRights | open access | |
dc.type.hasVersion | VoR |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [35716]
-
Biología Funcional [749]